| Literature DB >> 25965345 |
Ville Härmä1, Raisa Haavikko2, Johannes Virtanen1, Ilmari Ahonen3, Hannu-Pekka Schukov4, Sami Alakurtti5, Enkhee Purev6, Heiko Rischer7, Jari Yli-Kauhaluoma2, Vânia M Moreira2, Matthias Nees8, Kirsi-Marja Oksman-Caldentey7.
Abstract
The anti-invasive and anti-proliferative effects of betulins and abietane derivatives was systematically tested using an organotypic model system of advanced, castration-resistant prostate cancers. A preliminary screen of the initial set of 93 compounds was performed in two-dimensional (2D) growth conditions using non-transformed prostate epithelial cells (EP156T), an androgen-sensitive prostate cancer cell line (LNCaP), and the castration-resistant, highly invasive cell line PC-3. The 25 most promising compounds were all betulin derivatives. These were selected for a focused secondary screen in three-dimensional (3D) growth conditions, with the goal to identify the most effective and specific anti-invasive compounds. Additional sensitivity and cytotoxicity tests were then performed using an extended cell line panel. The effects of these compounds on cell cycle progression, mitosis, proliferation and unspecific cytotoxicity, versus their ability to specifically interfere with cell motility and tumor cell invasion was addressed. To identify potential mechanisms of action and likely compound targets, multiplex profiling of compound effects on a panel of 43 human protein kinases was performed. These target de-convolution studies, combined with the phenotypic analyses of multicellular organoids in 3D models, revealed specific inhibition of AKT signaling linked to effects on the organization of the actin cytoskeleton as the most likely driver of altered cell morphology and motility.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25965345 PMCID: PMC4428838 DOI: 10.1371/journal.pone.0126111
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 4Primary 3D screen.
PC-3 cells were cultured in 3D Matrigel ECM for 4 days and treated for 6 days with 25 betulin derivatives (from 2D high throughput screens), DMSO/vehicle control, and three reference compounds. A) Representative maximum intensity projections of confocal microscope stack images for selected compound treatments at 300 nM concentration (5× objective, scale 100 μm). B) Three graphs showing the relative impact on three morphometric parameters for 7 betulin derivatives, DMSO control, and one control compound (paclitaxel). Data scaling: displays the relative difference between median of Area/Complexity/Area Ratio, to DMSO control. Paclitaxel treatments and DMSO controls have been assigned values of -100 and 0, respectively. C) Hierarchical clustering was done using three morphological parameters derived from PC3 organoids: spheroid size (area), complexity and the number of dead cells. D) Wound healing curves of the two betulin derivatives 4 and 20, highlighting the 50% cut-off level (orange dashed line).
Estimated EC50 values for cell proliferation.
| PC-3 | LNCaP | EP156T | |
|---|---|---|---|
| Compound | 90.8 | 6.4 | 0.21 |
| Compound | 9.5 | 64.6 | 0.22 |
| Compound | 55.9 | 93.1 | 0.2 |
| Compound | 86.9 | 0.9 | 0.18 |
| Compound | 66.9 | 131.5 | 0.19 |
|
| 0.0012 | 0.0006 | 0.0008 |
Values have been calculated using Harmony High-Content Imaging and Analysis Software.